loading

Astria Therapeutics Inc (ATXS) 最新ニュース

pulisher
May 17, 2026

Ikena Oncology stock (US4517401090): takeover by Astria Therapeutics reshapes the story - AD HOC NEWS

May 17, 2026
pulisher
May 08, 2026

BioCryst Maintains 2026 ORLADEYO Revenue Guidance Amid Growth - HarianBasis.co

May 08, 2026
pulisher
May 06, 2026

BioCryst (NASDAQ: BCRX) takes $697.8M navenibart R&D hit after Astria deal - Stock Titan

May 06, 2026
pulisher
May 06, 2026

BioCryst Reports First Quarter 2026 Financial Results and Provides Business Update - GlobeNewswire

May 06, 2026
pulisher
Apr 27, 2026

BioCryst To Acquire Astria Therapeutics In $700M Deal - MSN

Apr 27, 2026
pulisher
Apr 23, 2026

Cantor Fitzgerald Downgrades Astria Therapeutics (ATXS) - MSN

Apr 23, 2026
pulisher
Apr 17, 2026

HC Wainwright & Co. Downgrades Astria Therapeutics (ATXS) - MSN

Apr 17, 2026
pulisher
Apr 13, 2026

Street Watch: Whats the MACD signal for Astria Therapeutics IncEntry Point & Reliable Price Breakout Alerts - baoquankhu1.vn

Apr 13, 2026
pulisher
Apr 12, 2026

Whale Trades: Is Astria Therapeutics Inc trading at a discount2026 Year in Review & Verified Technical Signals - baoquankhu1.vn

Apr 12, 2026
pulisher
Apr 11, 2026

Aug Momentum: Is Astria Therapeutics Inc stock forming a cup and handle2026 EndofYear Setup & Expert Curated Trade Setups - baoquankhu1.vn

Apr 11, 2026
pulisher
Apr 07, 2026

Published on: 2026-04-08 03:02:22 - baoquankhu1.vn

Apr 07, 2026
pulisher
Apr 06, 2026

BioCryst Appoints Sandeep M. Menon Chief Research and Development Officer - Yahoo Finance

Apr 06, 2026
pulisher
Apr 05, 2026

How The BioCryst Pharmaceuticals (BCRX) Narrative Is Shifting With Astria Deal And FY26 Targets - Yahoo Finance

Apr 05, 2026
pulisher
Mar 30, 2026

Meme Stocks: Can Astria Therapeutics Inc ride the EV wave2026 PostEarnings & Accurate Intraday Trade Tips - baoquankhu1.vn

Mar 30, 2026
pulisher
Mar 29, 2026

Can Astria Therapeutics Inc reach all time highs this yearQuarterly Portfolio Review & Low Risk Entry Point Guides - baoquankhu1.vn

Mar 29, 2026
pulisher
Mar 18, 2026

Astria Therapeutics (ATXS) price target decreased by 17.94% to 21.62 - MSN

Mar 18, 2026
pulisher
Mar 18, 2026

Performance Recap: Should I invest in Astria Therapeutics Inc before earningsQuarterly Portfolio Summary & Weekly Top Performers Watchlists - baoquankhu1.vn

Mar 18, 2026
pulisher
Mar 16, 2026

Trend Report: Whats the fair value of Astria Therapeutics Inc stock2026 Big Picture & Real-Time Buy Signal Alerts - baoquankhu1.vn

Mar 16, 2026
pulisher
Mar 16, 2026

BioCryst Pharmaceuticals Sees Profitable Quarter Amid Strategic Moves - StocksToTrade

Mar 16, 2026
pulisher
Mar 16, 2026

BioCryst Stock Surges After Strong Q4 Earnings and Astria Acquisition - timothysykes.com

Mar 16, 2026
pulisher
Mar 14, 2026

ATXS SEC FilingsAstria Therapeutics Inc 10-K, 10-Q, 8-K Forms - stocktitan.net

Mar 14, 2026
pulisher
Mar 10, 2026

BioCryst Pharma (BCRX) Subject to Prise Target Raise by Wedbush - Yahoo Finance

Mar 10, 2026
pulisher
Mar 07, 2026

Analyst Upgrade: Can Astria Therapeutics Inc stock outperform in a bear marketInsider Buying & AI Forecasted Stock Moves - baoquankhu1.vn

Mar 07, 2026
pulisher
Mar 06, 2026

Risks Report: Whats the fair value of Astria Therapeutics Inc stockJuly 2025 Pullbacks & Verified Entry Point Signals - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Moving Averages: What hedge funds are buying Astria Therapeutics IncAnalyst Upgrade & Growth Focused Stock Pick Reports - baoquankhu1.vn

Mar 06, 2026
pulisher
Mar 06, 2026

Evercore ISI sees long-term growth potential for BioCryst Pharmaceuticals, Inc. (BCRX) following Astria acquisition - MSN

Mar 06, 2026
pulisher
Mar 05, 2026

Less bullish OX40 field as Kyowa bid plowed under - BioWorld News

Mar 05, 2026
pulisher
Mar 02, 2026

A Look At BioCryst Pharmaceuticals (BCRX) Valuation As Net Income Turns Positive And Astria Deal Expands HAE Portfolio - Yahoo Finance

Mar 02, 2026
pulisher
Mar 01, 2026

BioCryst’s First Profitable Year Recasts Hereditary Angioedema Growth Story - Yahoo Finance

Mar 01, 2026
pulisher
Feb 27, 2026

Where is BioCryst Pharmaceuticals (BCRX) Headed According to the Street? - Finviz

Feb 27, 2026
pulisher
Feb 26, 2026

BCRX: $400M Blackstone term loan funds Astria deal, secured by assets, matures 2031, SOFR+4.5% - TradingView

Feb 26, 2026
pulisher
Feb 26, 2026

BioCryst (BCRX) Achieves Record Revenue and Profitability Milest - GuruFocus

Feb 26, 2026
pulisher
Feb 26, 2026

BioCryst (NASDAQ: BCRX) posts 2025 profit, keeps 2026 revenue outlook - Stock Titan

Feb 26, 2026
pulisher
Feb 26, 2026

BioCryst Reports Full Year 2025 Financial Results and Provides Business Update - The Manila Times

Feb 26, 2026
pulisher
Feb 26, 2026

Rare-disease drugmaker BioCryst turns first annual profit, wins FDA OK for kids - Stock Titan

Feb 26, 2026
pulisher
Feb 25, 2026

BioCryst (BCRX) Is Up 9.5% After Astria Deal And HAE Data Spotlight Has The Bull Case Changed? - Yahoo Finance

Feb 25, 2026
pulisher
Feb 24, 2026

ATXS Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan

Feb 24, 2026
pulisher
Feb 24, 2026

Aug Spikes: Can Astria Therapeutics Inc ride the EV waveQuarterly Earnings Report & Community Verified Trade Signals - baoquankhu1.vn

Feb 24, 2026
pulisher
Feb 23, 2026

Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition - Insider Monkey

Feb 23, 2026
pulisher
Feb 21, 2026

What are the future prospects of Astria Therapeutics Inc.2025 EndofYear Setup & Weekly High Potential Stock Alerts - mfd.ru

Feb 21, 2026
pulisher
Feb 21, 2026

Can Astria Therapeutics Inc. ride the EV wave2025 Earnings Surprises & Technical Analysis for Trade Confirmation - mfd.ru

Feb 21, 2026
pulisher
Feb 20, 2026

Is Astria Therapeutics Inc.’s ROE strong enoughTrade Volume Summary & Weekly Sector Rotation Insights - mfd.ru

Feb 20, 2026
pulisher
Feb 18, 2026

BioCryst (BCRX) Poised for Growth with Key Acquisition and Positive Outlook - GuruFocus

Feb 18, 2026
pulisher
Feb 17, 2026

Former 5% holder Vestal Point reports 0% stake in Astria (ATXS) - Stock Titan

Feb 17, 2026
pulisher
Feb 12, 2026

Glazer Capital reveals 6.61% Astria Therapeutics (ATXS) stake in 13G/A - Stock Titan

Feb 12, 2026
pulisher
Feb 11, 2026

Can Astria Therapeutics Inc. maintain its current growth rateJuly 2025 Trends & Capital Efficiency Focused Strategies - mfd.ru

Feb 11, 2026
pulisher
Feb 09, 2026

Analyst Calls: Should I invest in Astria Therapeutics Inc before earnings2025 Year in Review & Free Weekly Watchlist of Top Performers - baoquankhu1.vn

Feb 09, 2026
pulisher
Feb 09, 2026

Perceptive reports 0% stake in Astria Therapeutics (ATXS) after BioCryst deal - Stock Titan

Feb 09, 2026
pulisher
Feb 07, 2026

BioCryst Acquisition Of Astria Highlights Rare Disease Focus And Valuation Gap - Yahoo Finance

Feb 07, 2026
pulisher
Feb 06, 2026

All You Need to Know About Astria Therapeutics (ATXS) Rating Upgrade to Buy - MSN

Feb 06, 2026
$28.61
price down icon 4.35%
$89.17
price down icon 2.62%
$106.03
price down icon 2.64%
$55.18
price down icon 1.36%
ONC ONC
$279.68
price down icon 3.40%
$159.34
price down icon 1.30%
大文字化:     |  ボリューム (24 時間):